KOFFGO NEW SYRUP is a combination of Bromhexine, Chlorpheniramine maleate and Guaifenesin which belongs to the group of medicines called Mucolytics, Antihistamines and Nasal decongestants. It is used for symptomatic relief of productive cough. Avoid alcohol consumption while taking KOFFGO NEW SYRUP as it may increase drowsiness. KOFFGO NEW SYRUP is not recommended for use in patients with severe hypertension, severe coronary artery disease or porphyria. KOFFGO NEW SYRUP should be used with caution in patients with asthma, bronchitis, bronchiectasis or chronic lung disorders; severe liver or kidney disease; hypotension; ischaemic heart disease or cardiovascular collapse; fits; diabetes mellitus; a peptic ulcer; and glaucoma. KOFFGO NEW SYRUP is not recommended for use in pregnancy unless considered necessary. KOFFGO NEW SYRUP is not recommended for breastfeeding women unless considered necessary, as it may pass through breast milk. In children aged 2 to 12 years, KOFFGO NEW SYRUP should be used with caution.KOFFGO NEW SYRUP should be used with caution in patients over the age of 65. The most common side effects of taking KOFFGO NEW SYRUP are drowsiness and sedation, change in concentration, incoordination, dizziness, headache, blurred vision, nausea, vomiting, dry mouth and fatigue. If your symptoms worsen, consult your doctor.
No content available
